David E. Garfin

1.7k total citations
21 papers, 1.3k citations indexed

About

David E. Garfin is a scholar working on Molecular Biology, Nutrition and Dietetics and Spectroscopy. According to data from OpenAlex, David E. Garfin has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Nutrition and Dietetics and 4 papers in Spectroscopy. Recurrent topics in David E. Garfin's work include Prion Diseases and Protein Misfolding (6 papers), Trace Elements in Health (5 papers) and Advanced Proteomics Techniques and Applications (4 papers). David E. Garfin is often cited by papers focused on Prion Diseases and Protein Misfolding (6 papers), Trace Elements in Health (5 papers) and Advanced Proteomics Techniques and Applications (4 papers). David E. Garfin collaborates with scholars based in United States, Australia and Germany. David E. Garfin's co-authors include Howard M. Goodman, Brian J. McCarthy, H W Boyer, H M Goodman, Barry Polisky, P J Greene, Stanley B. Prusiner, Karen Oliva, Gillian Barker and Michael Quinn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

David E. Garfin

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Garfin United States 14 878 208 188 177 130 21 1.3k
A.H. Reisner Australia 16 739 0.8× 178 0.9× 88 0.5× 113 0.6× 162 1.2× 46 1.2k
Rachel M. Adams United States 14 956 1.1× 238 1.1× 202 1.1× 67 0.4× 98 0.8× 17 1.4k
Bruce H. Sells Canada 19 1.2k 1.4× 242 1.2× 57 0.3× 91 0.5× 141 1.1× 63 1.6k
Burghardt Scheibe Germany 10 971 1.1× 122 0.6× 539 2.9× 73 0.4× 120 0.9× 15 1.6k
Tom Berkelman United States 9 969 1.1× 224 1.1× 142 0.8× 129 0.7× 455 3.5× 25 1.5k
Gary R. Craven United States 19 1.8k 2.0× 365 1.8× 113 0.6× 213 1.2× 92 0.7× 49 2.1k
Beth L. Gillece-Castro United States 15 714 0.8× 194 0.9× 176 0.9× 56 0.3× 81 0.6× 19 1.2k
Joël Capdevielle France 15 1.0k 1.1× 120 0.6× 261 1.4× 61 0.3× 124 1.0× 20 1.5k
Jean‐Charles Sanchez Switzerland 13 992 1.1× 104 0.5× 356 1.9× 75 0.4× 176 1.4× 14 1.5k
Christopher F. Higgins United Kingdom 10 1.4k 1.5× 538 2.6× 58 0.3× 188 1.1× 170 1.3× 10 2.5k

Countries citing papers authored by David E. Garfin

Since Specialization
Citations

This map shows the geographic impact of David E. Garfin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Garfin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Garfin more than expected).

Fields of papers citing papers by David E. Garfin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Garfin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Garfin. The network helps show where David E. Garfin may publish in the future.

Co-authorship network of co-authors of David E. Garfin

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Garfin. A scholar is included among the top collaborators of David E. Garfin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Garfin. David E. Garfin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kastenholz, Bernd & David E. Garfin. (2009). Medicinal Plants: A Natural Chaperones Source for Treating Neurological Disorders. Protein and Peptide Letters. 16(2). 116–120. 10 indexed citations
2.
Kastenholz, Bernd, David E. Garfin, Jürgen Horst, & Kerstin Nagel. (2009). Plant metal chaperones: a novel perspective in dementia therapy. Amyloid. 16(2). 81–83. 7 indexed citations
3.
Garfin, David E. & Satinder Ahuja. (2005). Handbook of isoelectric focusing and proteomics. Medical Entomology and Zoology. 26 indexed citations
4.
Ahmed, Nuzhat, Gillian Barker, Karen Oliva, et al.. (2003). An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. PROTEOMICS. 3(10). 1980–1987. 159 indexed citations
5.
Harris, Andrew G., Peter G. Hains, Hong Chen, et al.. (2003). Strategies for the enrichment and identification of basic proteins in proteome projects. PROTEOMICS. 3(5). 569–579. 51 indexed citations
6.
Garfin, David E.. (2003). Two-dimensional gel electrophoresis: an overview. TrAC Trends in Analytical Chemistry. 22(5). 263–272. 62 indexed citations
7.
Molloy, Mark P., Nikhil Phadke, Hong Chen, et al.. (2002). Profiling the alkaline membrane proteome of Caulobacter crescentus with two-dimensional electrophoresis and mass spectrometry. PROTEOMICS. 2(7). 899–899. 46 indexed citations
8.
Garfin, David E.. (1990). [33] One-dimensional gel electrophoresis. Methods in enzymology on CD-ROM/Methods in enzymology. 182. 425–441. 278 indexed citations
9.
Garfin, David E.. (1990). [35] Isoelectric focusing. Methods in enzymology on CD-ROM/Methods in enzymology. 182. 459–477. 37 indexed citations
10.
Sb, Prusiner, et al.. (1980). Slow viruses: molecular properties of the agents causing scrapie in mice and hamsters.. PubMed. 39. 73–89. 2 indexed citations
11.
Garfin, David E., et al.. (1978). Suppression of Polyclonal B Cell Activation in Scrapieinfected C3H/HeJ Mice. The Journal of Immunology. 120(6). 1986–1990. 16 indexed citations
12.
Prusiner, Stanley B., W. J. Hadlow, David E. Garfin, et al.. (1978). Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry. 17(23). 4993–4999. 79 indexed citations
13.
Garfin, David E., et al.. (1978). Mitogen Stimulation of Splenocytes from Mice Infected with Scrapie Agent. The Journal of Infectious Diseases. 138(3). 396–400. 9 indexed citations
14.
Garfin, David E., D P Stites, W. J. Hadlow, Carina Eklund, & Stanley B. Prusiner. (1977). Cellular immune interactions of splenocytes from scrapie- -infected mice. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 145(10). 1249–3696. 1 indexed citations
15.
Garfin, David E., Jo‐Ann C. Leong, & Howard M. Goodman. (1976). The EcoRI site of simian virus 40 deoxyribonucleic acid: Nucleotide sequences of the minus and plus strands. Biochemical and Biophysical Research Communications. 68(2). 369–374. 1 indexed citations
16.
Garfin, David E. & Stanley Mandeles. (1975). Sequences of oligonucleotides prepared from tobacco mosaic virus ribonucleic acid. Virology. 64(2). 388–399. 16 indexed citations
17.
Polisky, Barry, P J Greene, David E. Garfin, et al.. (1975). Specificity of substrate recognition by the EcoRI restriction endonuclease.. Proceedings of the National Academy of Sciences. 72(9). 3310–3314. 273 indexed citations
18.
Garfin, David E., Herbert W. Boyer, & Howard M. Goodman. (1975). Sequences spanning the EcoRI substrate site. Nucleic Acids Research. 2(10). 1851–1866. 13 indexed citations
19.
Taylor, Jonathan M., et al.. (1974). Tumor virus ribonucleic acid directed deoxyribonucleic acid synthesis. Nucleotide sequence at the 5' terminus of nascent deoxyribonucleic acid. Biochemistry. 13(15). 3159–3163. 32 indexed citations
20.
Garfin, David E. & Howard M. Goodman. (1974). Nucleotide sequences at the cleavage sites of two restriction endonucleases from Hemophilus parainfluenzae. Biochemical and Biophysical Research Communications. 59(1). 108–116. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026